CEL-SCI Corporation today announced that in a recent meeting the U.S. Food and Drug Administration (FDA) concurred with the Company's approach to patient selection using low PD-L1 tumor expression in ...

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global leader in the discovery, development, manufacturing, and delivery of next-generation vaccines and ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

It comes after England's health watchdog launched a probe into a celebrity-backed prviate menopause clinic over allegations it was prescribing patients high levels of HRT.

Net revenue of $70.8 million in Q3 2024 driven by 30% increase in UDENYCA® net revenue, quarter-over-quarter – ...

Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a leading management services organization (MSO) of retina ...

Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r adverse risk AML patients selected for oral presentation on Saturday, December 7th –– ...

Electronics and Telecommunications Research Institute (ETRI) stated that they have successfully developed a new technology ...

Investment in artificial intelligence (AI) is rising fast. The International Data Corporation projects global spending on AI R&D will reach ...

One Latino civil rights organization has released a new set of guidelines to inform people of their federally protected rights while getting medical care.